GAPNA discusses how advanced practice practitioners are well-positioned to encourage healthy lifestyles among older adults, to include activities that help attain/maintain lean muscle mass, regardless of BMI, to reduce chronic pain and frailty.
Three types of musculoskeletal pain and differences in diagnostic evaluation and treatment were evaluated in an in-depth systematic review to create a gold standard of care.
The Guideline Development Group of the WHO agreed that its recommendations on managing chronic pain in children would be based on the principles that access to pain management is a fundamental human right and children have a right to the highest possible standard of health.
The authors of this review present key epidemiologic data about cancer patients vulnerable for each pain syndrome along with evidence for the management for each condition.
In patients with dementia, pain is a correlate or prodromal symptom rather than a direct cause of dementia.
The AAAHC developed the toolkit as an informational resource for managing pain in both primary care and surgical practices.
The FDA reported that between July 27, 2016 and July 27, 2020, a total of 107,728 medical device reports (MDRs) associated with SCS devices intended for pain were received.
Fibromyalgia is a chronic pain condition characterized by widespread musculoskeletal pain, sleep disturbance, fatigue.
Authors of a paper share their perspectives on the topic of chronic pain in individuals with mental health disorders.
The FDA has approved ReActiv8® (Mainstay Medical), an implantable neurostimulation system, for the treatment of intractable chronic low back.
